1. Home
  2. DSS vs CHRO Comparison

DSS vs CHRO Comparison

Compare DSS & CHRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DSS
  • CHRO
  • Stock Information
  • Founded
  • DSS 1984
  • CHRO 2002
  • Country
  • DSS United States
  • CHRO United States
  • Employees
  • DSS N/A
  • CHRO N/A
  • Industry
  • DSS Containers/Packaging
  • CHRO
  • Sector
  • DSS Consumer Discretionary
  • CHRO
  • Exchange
  • DSS Nasdaq
  • CHRO Nasdaq
  • Market Cap
  • DSS 8.0M
  • CHRO 8.1M
  • IPO Year
  • DSS N/A
  • CHRO 2024
  • Fundamental
  • Price
  • DSS $0.97
  • CHRO $1.37
  • Analyst Decision
  • DSS
  • CHRO Strong Buy
  • Analyst Count
  • DSS 0
  • CHRO 1
  • Target Price
  • DSS N/A
  • CHRO N/A
  • AVG Volume (30 Days)
  • DSS 14.3K
  • CHRO 2.1M
  • Earning Date
  • DSS 05-13-2025
  • CHRO 05-14-2025
  • Dividend Yield
  • DSS N/A
  • CHRO N/A
  • EPS Growth
  • DSS N/A
  • CHRO N/A
  • EPS
  • DSS N/A
  • CHRO N/A
  • Revenue
  • DSS $19,097,000.00
  • CHRO N/A
  • Revenue This Year
  • DSS N/A
  • CHRO N/A
  • Revenue Next Year
  • DSS N/A
  • CHRO N/A
  • P/E Ratio
  • DSS N/A
  • CHRO N/A
  • Revenue Growth
  • DSS N/A
  • CHRO N/A
  • 52 Week Low
  • DSS $0.77
  • CHRO $0.45
  • 52 Week High
  • DSS $1.94
  • CHRO $3.80
  • Technical
  • Relative Strength Index (RSI)
  • DSS 56.41
  • CHRO 46.67
  • Support Level
  • DSS $0.82
  • CHRO $1.29
  • Resistance Level
  • DSS $1.00
  • CHRO $1.65
  • Average True Range (ATR)
  • DSS 0.06
  • CHRO 0.20
  • MACD
  • DSS 0.01
  • CHRO 0.02
  • Stochastic Oscillator
  • DSS 83.33
  • CHRO 13.81

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

About CHRO Chromocell Therapeutics Corporation

Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic, visceral pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.

Share on Social Networks: